FDA Allows Certain Rule Exemptions for Supply Chain Crisis
Due to the spread of the Omicron variant and severe supply chain shortages, the U.S. Food and Drug Administration (FDA) has reissued a list of temporary guidances that will remain in effect. These guidances provide flexibility to help minimize the impact of these supply chain disruptions on product availability.